Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

DRTS - Alpha Tau Medical Ltd


IEX Last Trade
2.38
0.120   5.042%

Share volume: 40,417
Last Updated: Fri 30 Aug 2024 09:59:29 PM CEST
Surgical and Medical Instrument Manufacturing : -0.56%

PREVIOUS CLOSE
CHG
CHG%

$2.26
0.12
5.31%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Performance
5 Days
11.36%
1 Month
11.37%
3 Months
-2.00%
6 Months
-16.95%
1 Year
-24.85%
2 Year
-73.43%
Key data
Stock price
$2.38
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$1.75 - $3.90
52 WEEK CHANGE
-$0.32
MARKET CAP 
170.693 M
YIELD 
N/A
SHARES OUTSTANDING 
69.671 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/14/2024
BETA 
0.30
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$15,576
AVERAGE 30 VOLUME 
$23,257
Company detail
CEO:
Region: US
Website:
Employees: 86
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

alpha tau medical (http://www.alphataumedical.com/) focuses on research, development and commercialization of alpha dart (diffusing alpha-emitters radiation therapy) for the treatment of solid cancer tumors. alpha dart technology, initially developed at tel aviv university, was shown to be effective and safe for treating different types of cancer in multiple animal studies. the company is running its first clinical trial in several sites in the eu. breakthrough technology for cancer treatment the alpha dart breakthrough technology utilizes alpha radiation to treat cancer and enables highly potent and conformal radiotherapy. alpha dart treats solid tumors with interstitial radioactive seeds that continually release short-lived alpha emitting atoms into the tumor.

Recent news